Beta-2 microglobulin and all-cause mortality in the era of high-flux hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study.
Eiichiro KandaDaniel MuenzBrian BieberAleix CasesFrancesco LocatelliFriedrich K PortRoberto Pecoits-FilhoBruce M RobinsonJeffrey PerlPublished in: Clinical kidney journal (2020)
DRA-related hospitalizations decreased over 10-fold from 1998 to 2018. Serum β2M remains positively associated with mortality, even in the current high-flux HD era.